Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 10—October 2007
Dispatch

Super-Sentinel Chickens and Detection of Low-Pathogenicity Influenza Virus

Philip I. Marcus*Comments to Author , Theodore Girshick†, Louis van der Heide*, and Margaret J. Sekellick*
Author affiliations: *University of Connecticut, Storrs, Connecticut, USA; †Charles River Specific Pathogen Free Avian Supplies, Storrs, Connecticut, USA;

Main Article

Table 1

Seroconversion in influenza A virus–infected 3-week-old chickens given water or water + interferon*

Infection type† No. chickens
Water Water + interferon‡ Total
Overtly infected 4/8§ 8/8 16
Sentinel 2/32 31/31 63
Combined 6/40 39/39 79

*Represents 4 independent trials.
†Overtly infected birds were mixed with uninfected sentinel cage mates, the latter to become infected naturally.
‡Recombinant chicken interferon-α at 2,000 U/mL (5).
§No. positive birds/total no. receiving treatment, scored by agar gel precipitin or hemagglutination inhibition tests.

Main Article

References
  1. Cardona  C. Low-pathogenicity avian influenza virus outbreaks in commercial poultry in California. In: The threat of pandemic influenza: are we ready? Washington: National Academies Press; 2005. p. 243–53.
  2. Chin  PS, Hoffman  E, Webby  R, Webster  RG, Guan  Y, Peiris  M, Molecular evolution of H6 influenza viruses from poultry in southeastern China: prevalence of H6N1 influenza viruses possessing seven A/Hong Kong/156/97 (H5N1)–like genes in poultry. J Virol. 2002;76:50716. DOIPubMed
  3. Lee  C-W, Swayne  DE, Linares  JA, Senns  DA, Suarez  DI. H5N2 avian influenza outbreak in Texas in 2004: the first highly pathogenic strain in the United States in 20 years? J Virol. 2005;79:1141221. DOIPubMed
  4. Kuiken  T, Leighton  FA, Fouchier  RAM, LeDuc  JW, Peitis  JSM, Schdel  A, Pathogen surveillance in animals. Science. 2005;309:16801. DOIPubMed
  5. Sekellick  MJ, Ferrandino  AF, Hopkins  DA, Marcus  PI. Chicken interferon gene: cloning, expression, and analysis. J Interferon Res. 1994;14:719.PubMed
  6. Marcus  PI, van der Heide  L, Sekellick  MJ. Interferon action on avian viruses. I. Oral administration of chicken interferon-α ameliorates Newcastle disease. J Interferon Cytokine Res. 1999;19:8815. DOIPubMed
  7. Pei  J, Sekellick  MJ, Marcus  PI, Choi  I-S, Collisson  EW. Chicken interferon type I inhibits infectious bronchitis virus (IBV) replication and associated respiratory illness. J Interferon Cytokine Res. 2001;21:10717. DOIPubMed
  8. Mo  CW, Cao  TC, Lim  BL. The in vivo and in vitro effects of chicken interferon-alpha on infectious bursal disease virus and Newcastle disease infection. Avian Dis. 2001;45:38999. DOIPubMed
  9. Lu  H, Castro  AE. Evaluation of the infectivity, length of infection, and immune response of a low-pathogenicity H7N2 avian influenza virus in specific-pathogen-free chickens. Avian Dis. 2004;48:26370. DOIPubMed
  10. Sekellick  MJ, Carra  SA, Bowman  A, Marcus  PI. Transient resistance of influenza virus to interferon action attributed to random packaging and activity of NS genes. J Interferon Cytokine Res. 2000;20:96370. DOIPubMed
  11. Cauthen  AN, Swayne  DE, Sekellick  MJ, Marcus  PI, Suarez  DL. Amelioration of influenza pathogenesis in chickens attributed to the enhanced interferon-inducing capacity of a virus with a truncated NS1 gene. J Virol. 2007;81:183847. DOIPubMed
  12. Beilharz  MW, Fleischmann  WR Jr, eds. Special topics issue: oral use of interferons and cytokines. J Interferon Cytokine Res. 1999;19:813979. DOI
  13. Suresh  M, Karaca  K, Foster  D, Sharma  JM. Molecular and functional characterization of turkey interferon. J Virol. 1995;69:815963.PubMed
  14. Xia  C, Liu  J, Wu  ZG, Lin  CY, Wang  M. The interferon-alpha genes from three chicken lines and its effects on H9N2 influenza viruses. Anim Biotechnol. 2004;15:7788. DOIPubMed
  15. Schultz  U, Rinderle  C, Sekellick  MJ, Marcus  PI, Staeheli  P. Recombinant chicken interferon from Escherichia coli and transfected COS cells is biologically active. Eur J Biochem. 1995;229:736. DOIPubMed

Main Article

Page created: July 02, 2010
Page updated: July 02, 2010
Page reviewed: July 02, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external